Preprint Article Version 1 This version is not peer-reviewed

Corneal Epithelial Wavefront Error as a Novel Objective Biomarker Diagnostic Marker for Epithelial Basement Membrane Dystrophy

Version 1 : Received: 30 August 2024 / Approved: 30 August 2024 / Online: 30 August 2024 (19:20:56 CEST)

How to cite: Grauvogl, V.; Mayer, W. J.; Siedlecki, J.; Mohr, N.; Dirisamer, M.; Priglinger, S. G.; Kassumeh, S.; Luft, N. Corneal Epithelial Wavefront Error as a Novel Objective Biomarker Diagnostic Marker for Epithelial Basement Membrane Dystrophy. Preprints 2024, 2024082276. https://doi.org/10.20944/preprints202408.2276.v1 Grauvogl, V.; Mayer, W. J.; Siedlecki, J.; Mohr, N.; Dirisamer, M.; Priglinger, S. G.; Kassumeh, S.; Luft, N. Corneal Epithelial Wavefront Error as a Novel Objective Biomarker Diagnostic Marker for Epithelial Basement Membrane Dystrophy. Preprints 2024, 2024082276. https://doi.org/10.20944/preprints202408.2276.v1

Abstract

Synopsis Corneal epithelial wavefront error and epithelial thickness variance qualify as highly sensitive and specific biomarkers for epithelial basement membrane dystrophy (EBMD). The biomarkers show a normalization after treatment of EBMD with phototherapeutic keratectomy. Purpose: To gauge the diagnostic value of a novel spectral-domain optical coherence tomography (SD-OCT) based imaging modality for simultaneous morphological (thickness profile) and refractive (optical wavefront) assessment of the corneal epithelial layer in one of the most common but often underdiagnosed corneal dystrophies: epithelial basement membrane dystrophy (EBMD). Methods: In this prospective observational study, a total of 32 eyes of 32 patients diagnosed with EBMD and 32 eyes of 32 healthy control subjects were examined with high-resolution anterior segment SD-OCT (MS-39; CSO, Florence, Italy). Various epithelial thickness and epithelial wavefront derived terms were compared between groups and receiver operating characteristic (ROC) curves were computed to analyze the diagnostic capacity of the respective parameters. A total of 17 of 32 EBMD patients underwent treatment with phototherapeutic keratectomy (PTK) and were followed up for 3 months. Results: Epithelial thickness variance (60.4 ± 56.7 µm versus 7.6 ± 6.1 µm) and interquartile range (11.0±6.9 versus 3.3±1.9 µm) were markedly elevated in EBMD patients as compared with healthy controls (both with p < 0.001). Epithelial wavefront analysis showed a highly statistically significant excess in all examined aberration terms in EBMD patients (all with p < 0.001). Significantly greater areas under the curve (AUC) were yielded by the epithelial wavefront derived parameters (e.g. total epithelial wavefront error: AUC = 0.966; 95% confidence interval (CI) 0.932 – 1) than by the epithelial thickness-derived parameters (e.g., variance: AUC = 0.919; 95% CI 0.848 – 0.990). Conclusion: Corneal epithelial wavefront aberrometry proved valuable as an objective biomarker for EBMD with high sensitivity and specificity. PTK resulted in a reduction of morphological and refractive epithelial irregularities in EBMD.

Keywords

Cornea; Dystrophy; Treatment Lasers; Ocular surface

Subject

Medicine and Pharmacology, Ophthalmology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.